Other
Clinical related costs
Incyte Clinical related costs increased by 1.0% to $177.7M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33.9%, from $132.73M to $177.7M. Over 4 years (FY 2021 to FY 2025), Clinical related costs shows an upward trend with a 12.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2021
Last reportedQ1 2026Apr 28, 2026
Metric ID:
other_accrued_clinical_related_costs_currentHistorical Data
16 periods
| Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $109.49M | $152.76M | $130.57M | $117.42M | $137.78M | $100.28M | $109.62M | $94.55M | $105.68M | $120.56M | $132.45M | $132.73M | $146.29M | $157.68M | $175.93M | $177.7M |
| QoQ Change | — | +39.5% | -14.5% | -10.1% | +17.3% | -27.2% | +9.3% | -13.7% | +11.8% | +14.1% | +9.9% | +0.2% | +10.2% | +7.8% | +11.6% | +1.0% |
| YoY Change | — | — | +19.3% | — | — | -34.4% | -16.0% | -19.5% | -23.3% | +20.2% | +20.8% | +40.4% | +38.4% | +30.8% | +32.8% | +33.9% |
Range$94.55M – $177.7M
CAGR+13.8%
Avg YoY Growth+12.0%
Median YoY Growth+20.5%
Current Streak8 quarters growth
Frequently Asked Questions
- What is Incyte's clinical related costs?
- Incyte (INCY) reported clinical related costs of $177.7M in Q1 2026.
- How has Incyte's clinical related costs changed year-over-year?
- Incyte's clinical related costs increased by 33.9% year-over-year, from $132.73M to $177.7M.
- What is the long-term trend for Incyte's clinical related costs?
- Over 4 years (2021 to 2025), Incyte's clinical related costs has grown at a 12.6% compound annual growth rate (CAGR), from $109.49M to $175.93M.